Bullish & Foolish
Full AEMD fundamentals All 466 on the Survival Watch

AEMDAethlon Medical, Inc.

Is Aethlon Medical struggling financially?

Yes, by its own account. Aethlon Medical told the SEC on 10 Jun 2026, in Form 10-K, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jun 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$1.9M
Source filing
10-K 10 Jun 2026
Balance sheet
30 Jun 2026

Cash runway

  • 7months

    If the burn speeds up

    Empty by Jan 2027

  • 10months

    If it eases off

    Empty by Apr 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$4.9M

÷

Cash burned over the last 12 months

$7.0M

What Aethlon Medical told the SEC

…during the preparation of the financial statements included in this Annual Report, management concluded that there were conditions and events which raised substantial doubt as to the Company’s ability to continue as a going concern within twelve months after the date of the issuance of the financial statements included in this Annual Report. The uncertainty regarding our ability to continue as a going concern…

Aethlon Medical, Inc., Form 10-K, filed 10 Jun 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Cash burn is narrowing It is spending 47% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt